These findings suggest that obesity impairs vascular and alveolar regeneration by suppressing adiponectin-VEGF/VEGFR2 signaling, and adiponectin may be one of the therapeutic targets to improve regenerative ability in obese lungs. Here, ADIPOQ is linked to Obesity.